Astegolimab
Stories
-
Hoffmann-La Roche posts results of Phase III astegolimab trial in COPD
The study enrolled 1380 participants and completed primary data collection on June 24, 2025. Results were first posted on ClinicalTrials.gov on October 28, 2026.